2017
DOI: 10.1186/s12963-017-0142-4
|View full text |Cite
|
Sign up to set email alerts
|

Choice of relative or cause-specific approach to cancer survival analysis impacts estimates differentially by cancer type, population, and application: evidence from a Canadian population-based cohort study

Abstract: BackgroundCause-specific (CS) and net survival in a relative survival framework (RS) are two of the most common methods for estimating cancer survival. In this paper, we assess the differences in results produced by two permutations of cause-specific and relative survival applied to estimating cancer survival and disparities in cancer survival, using data from First Nations and non-Aboriginal populations in Canada.MethodsSubjects were members of the 1991 Canadian Census Mortality Cohort, a population-based coh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(17 citation statements)
references
References 24 publications
(33 reference statements)
1
16
0
Order By: Relevance
“…Cancer data were obtained from the South Australian Cancer Registry (SACR), a population-based registry coding cancer diagnoses to the International Classification of Diseases for Oncology (ICD-O-3) [40] and deaths to ICD-10. A broad definition of cancer death [41] was adopted to avoid potential misattribution to other organ sites and undercounting of deaths [10, 42]. Cancer stage at diagnosis was summarised using SEER methods [43] as: localised - confined to tissue of origin; regional - invaded adjacent tissue or regional nodes; distant - spread to distant lymph nodes or other organs, or to leukaemia (C42.1); and unknown stage where insufficient staging data were available.…”
Section: Methodsmentioning
confidence: 99%
“…Cancer data were obtained from the South Australian Cancer Registry (SACR), a population-based registry coding cancer diagnoses to the International Classification of Diseases for Oncology (ICD-O-3) [40] and deaths to ICD-10. A broad definition of cancer death [41] was adopted to avoid potential misattribution to other organ sites and undercounting of deaths [10, 42]. Cancer stage at diagnosis was summarised using SEER methods [43] as: localised - confined to tissue of origin; regional - invaded adjacent tissue or regional nodes; distant - spread to distant lymph nodes or other organs, or to leukaemia (C42.1); and unknown stage where insufficient staging data were available.…”
Section: Methodsmentioning
confidence: 99%
“…The aim of our study is to address the question of "which framework one should use for estimating net cancer survival" by quantifying differences in cancer survival estimates through relative and cause-specific survival approaches using the new life tables and the SEER cause of death classification. Several studies have addressed this topic (7,(14)(15)(16), but to our knowledge, this is the first comparison after the new life tables have been introduced.…”
Section: Introductionmentioning
confidence: 99%
“…Unfortunately, these particular variables were not collected by the registry, and so we were unable to evaluate their potential impact on survival. Finally, cause‐specific survival, particularly with a narrow definition of cancer death, as used herein, may overestimate survival; therefore, it is possible that true survival among AN people may be lower than the survival estimated herein.…”
Section: Discussionmentioning
confidence: 83%